These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19470383)

  • 1. The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats.
    Henley C; Davis J; Miller G; Shatzen E; Cattley R; Li X; Martin D; Yao W; Lane N; Shalhoub V
    Eur J Pharmacol; 2009 Aug; 616(1-3):306-13. PubMed ID: 19470383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats.
    Lopez I; Mendoza FJ; Aguilera-Tejero E; Perez J; Guerrero F; Martin D; Rodriguez M
    Kidney Int; 2008 Feb; 73(3):300-7. PubMed ID: 18004298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.
    Miller G; Davis J; Shatzen E; Colloton M; Martin D; Henley CM
    Nephrol Dial Transplant; 2012 Jun; 27(6):2198-205. PubMed ID: 22036941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia.
    Tamagaki K; Yuan Q; Ohkawa H; Imazeki I; Moriguchi Y; Imai N; Sasaki S; Takeda K; Fukagawa M
    Nephrol Dial Transplant; 2006 Mar; 21(3):651-9. PubMed ID: 16311258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism.
    Henley C; Colloton M; Cattley RC; Shatzen E; Towler DA; Lacey D; Martin D
    Nephrol Dial Transplant; 2005 Jul; 20(7):1370-7. PubMed ID: 15855208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcimimetics, mechanisms of action and therapeutic applications].
    Ureña P; Legoupil N; de Vernejoul MC
    Presse Med; 2005 Sep; 34(15):1095-100. PubMed ID: 16334889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection.
    Shiizaki K; Hatamura I; Nakazawa E; Ogura M; Masuda T; Akizawa T; Kusano E
    Med Mol Morphol; 2008 Jun; 41(2):76-82. PubMed ID: 18592161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patients.
    Walter S; Baruch A; Dong J; Tomlinson JE; Alexander ST; Janes J; Hunter T; Yin Q; Maclean D; Bell G; Mendel DB; Johnson RM; Karim F
    J Pharmacol Exp Ther; 2013 Aug; 346(2):229-40. PubMed ID: 23674604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism.
    Colloton M; Shatzen E; Miller G; Stehman-Breen C; Wada M; Lacey D; Martin D
    Kidney Int; 2005 Feb; 67(2):467-76. PubMed ID: 15673294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration.
    Díaz-Tocados JM; Rodríguez-Ortiz ME; Almadén Y; Pineda C; Martínez-Moreno JM; Herencia C; Vergara N; Pendón-Ruiz de Mier MV; Santamaría R; Rodelo-Haad C; Casado-Díaz A; Lorenzo V; Carvalho C; Frazão JM; Felsenfeld AJ; Richards WG; Aguilera-Tejero E; Rodríguez M; López I; Muñoz-Castañeda JR
    Kidney Int; 2019 May; 95(5):1064-1078. PubMed ID: 30878213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats.
    Lopez I; Mendoza FJ; Guerrero F; Almaden Y; Henley C; Aguilera-Tejero E; Rodriguez M
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1376-85. PubMed ID: 19321594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
    Lindberg JS; Moe SM; Goodman WG; Coburn JW; Sprague SM; Liu W; Blaisdell PW; Brenner RM; Turner SA; Martin KJ
    Kidney Int; 2003 Jan; 63(1):248-54. PubMed ID: 12472790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium.
    Cozzolino M; Lu Y; Finch J; Slatopolsky E; Dusso AS
    Kidney Int; 2001 Dec; 60(6):2109-17. PubMed ID: 11737585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats.
    Jung S; Querfeld U; Müller D; Rudolph B; Peters H; Krämer S
    J Hypertens; 2012 Nov; 30(11):2182-91. PubMed ID: 22902873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of bone mineralization by cinacalcet is associated with a significant reduction in calcitriol-induced vascular calcification in uremic rats.
    De Schutter TM; Behets GJ; Jung S; Neven E; D'Haese PC; Querfeld U
    Calcif Tissue Int; 2012 Nov; 91(5):307-15. PubMed ID: 22926202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
    Finch JL; Tokumoto M; Nakamura H; Yao W; Shahnazari M; Lane N; Slatopolsky E
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1315-22. PubMed ID: 20200094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinacalcet suppresses calcification of the aorta and heart in uremic rats.
    Kawata T; Nagano N; Obi M; Miyata S; Koyama C; Kobayashi N; Wakita S; Wada M
    Kidney Int; 2008 Nov; 74(10):1270-7. PubMed ID: 18813289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
    Slatopolsky E; Finch JL; Brown AJ; Ritter CS; Mizobuchi M; Plum LA; Clagett-Dame M; Sicinski RR; DeLuca HF
    J Bone Miner Res; 2007 May; 22(5):686-94. PubMed ID: 17444814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands.
    Rodriguez ME; Almaden Y; Cañadillas S; Canalejo A; Siendones E; Lopez I; Aguilera-Tejero E; Martin D; Rodriguez M
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1390-5. PubMed ID: 17200160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.